EW
Edwards Lifesciences Corporation
Healthcare
$83.20
as of May 21, 2026
Sign in to add EW to your portfolio.
Sign inMarket cap
$47.77B
P/E (TTM)
44.0x
EPS (TTM)
$1.89
Dividend yield
—
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $5.23B | $1.50B | $1.40B | 76.6% | 30.8% | $2.41 |
| 2022 | $5.38B | $1.52B | $953.40M | 78.3% | 31.6% | $2.46 |
| 2023 | $5.01B | $1.40B | $629.50M | 79.3% | 28.5% | $2.31 |
| 2024 | $5.44B | $4.17B | $289.90M | 79.5% | 25.3% | $6.98 |
| 2025 | $6.07B | $1.07B | $1.33B | 78.1% | 27.0% | $1.84 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $82.13 | $83.20 | 3.73M |
| May 20, 2026 | $81.74 | $82.97 | 4.03M |
| May 19, 2026 | $82.29 | $82.16 | 4.09M |
| May 18, 2026 | $81.14 | $82.39 | 4.18M |
| May 15, 2026 | $80.14 | $81.38 | 4.67M |
| May 14, 2026 | $81.46 | $81.34 | 3.31M |
| May 13, 2026 | $79.55 | $81.39 | 5.34M |
| May 12, 2026 | $77.76 | $79.73 | 5.08M |
| May 11, 2026 | $79.73 | $77.17 | 5.26M |
| May 08, 2026 | $82.89 | $79.96 | 4.03M |
| May 07, 2026 | $83.25 | $82.76 | 3.33M |
| May 06, 2026 | $82.73 | $83.20 | 5.08M |
| May 05, 2026 | $83.95 | $82.91 | 3.29M |
| May 04, 2026 | $83.66 | $83.33 | 3.30M |
| May 01, 2026 | $84.01 | $83.98 | 6.58M |
| Apr 30, 2026 | $81.53 | $83.50 | 6.64M |
| Apr 29, 2026 | $81.95 | $81.22 | 5.01M |
| Apr 28, 2026 | $84.13 | $82.28 | 5.84M |
| Apr 27, 2026 | $83.54 | $83.46 | 7.17M |
| Apr 24, 2026 | $82.50 | $84.15 | 11.82M |
| Apr 23, 2026 | $81.53 | $79.72 | 6.23M |
| Apr 22, 2026 | $80.14 | $81.53 | 4.94M |
| Apr 21, 2026 | $81.48 | $79.71 | 4.88M |
| Apr 20, 2026 | $80.95 | $81.44 | 5.51M |
Profitability & balance
- ROE (TTM)
- 10.5%
- Gross margin
- 78.0%
- Operating margin
- 27.6%
- Net margin
- 17.3%
- Debt / equity
- 0.07